State of Illinois
92nd General Assembly
Legislation

   [ Search ]   [ PDF text ]   [ Legislation ]   
[ Home ]   [ Back ]   [ Bottom ]


[ Engrossed ][ Enrolled ][ House Amendment 001 ]
[ House Amendment 002 ][ Senate Amendment 001 ][ Senate Amendment 002 ]
[ Senate Amendment 003 ]


92_HB2391

 
                                               LRB9205784LBpc

 1        AN ACT concerning animal control.

 2        Be  it  enacted  by  the People of the State of Illinois,
 3    represented in the General Assembly:

 4        Section 1.  Short title.  This Act may be  cited  as  the
 5    Humane Euthanasia in Animal Shelters Act.

 6        Section  5.  Definitions.  The  following  terms have the
 7    meanings indicated, unless the context requires otherwise:
 8        "Animal" means any bird, fish, reptile, or  mammal  other
 9    than man.
10        "Board"  means  the Veterinary Licensing and Disciplinary
11    Board.
12        "DEA" means the United States Department of Justice  Drug
13    Enforcement Administration.
14        "Department"   means   the   Department  of  Professional
15    Regulation.
16        "Director"  means  the  Director  of  the  Department  of
17    Professional Regulation.
18        "Euthanasia agency" means a law  enforcement  agency,  an
19    animal  control  agency  or animal shelter licensed under the
20    Animal Welfare Act, a duly incorporated humane society, or  a
21    society  for  the  prevention of cruelty to animals, that has
22    been inspected and certified by the Department.
23        "Euthanasia drugs"  means  sodium  pentobarbital  or  any
24    other  Schedule  III  or Schedule II narcotic or non-narcotic
25    euthanasia drug indicated for animal euthanasia,  as  defined
26    by  the  Illinois  Controlled  Substances Act, that has first
27    been  approved  in  writing  for  use  by  the  Federal  Drug
28    Authority, the Department, the Euthanasia Task Force, and the
29    Board.
30        "Euthanasia technician" means  a  person  employed  by  a
31    euthanasia  agency or working under the direct supervision of
 
                            -2-                LRB9205784LBpc
 1    a veterinarian and who is certified by the Department.
 2        "Euthanasia Task Force" means a task force established by
 3    the Board  for  the  purposes  of  training,  examining,  and
 4    inspecting euthanasia agencies and euthanasia technicians.
 5        "Veterinarian"  means  a  person  holding  the  degree of
 6    Doctor of Veterinary  Medicine  who  is  licensed  under  the
 7    Veterinary Medicine and Surgery Practice Act of 1994.

 8        Section 10.  Euthanasia Task Force.
 9        (a)  A  Euthanasia Task Force shall be established by the
10    Board for the purposes of training and  examining  euthanasia
11    agencies   and   euthanasia   technicians  and  for  annually
12    inspecting euthanasia agencies.
13        (b)  The membership of the Euthanasia  Task  Force  shall
14    consist  of  no  fewer than 16 members appointed by the Board
15    and shall include at least  one  member  of  the  Board.  New
16    members  shall  be  nominated  by  either  the  Board  or the
17    Euthanasia Task Force and shall be confirmed  by  the  Board.
18    Applicants  for a position on the Euthanasia Task Force shall
19    be euthanasia technicians employed by a euthanasia agency  or
20    a veterinarian.
21        (c)  Each member of the Euthanasia Task Force shall serve
22    for  2  years,  upon  the  approval  of the Board, but may be
23    removed for just cause.   A Euthanasia Task Force member  may
24    be  reappointed.   If  there  is a vacancy for any cause, the
25    Euthanasia Task Force shall  nominate  and  the  Board  shall
26    confirm a successor to fill the unexpired term.
27        (d)  Each  member  of  the Euthanasia Task Force shall be
28    entitled to receive a per diem stipend at a rate set  by  the
29    Director  and shall be reimbursed for all authorized expenses
30    incurred in the exercise of his or her duties.
31        (e)  The duties of  the  Euthanasia  Task  Force  members
32    shall include all of the following:
33             (1)  coordinating  and providing euthanasia training
 
                            -3-                LRB9205784LBpc
 1        classes (which may be done with the aid of  the  Illinois
 2        Federation   of  Humane  Societies,  the  Illinois  State
 3        Veterinary  Medical  Association  or  other   appropriate
 4        entities) twice yearly or as needed;
 5             (2)  inspecting and certifying euthanasia agencies;
 6             (3)  reviewing     the     applications,    records,
 7        performance, methods, and procedures used  by  euthanasia
 8        agencies  and persons seeking to be certified or to renew
 9        their certification as a euthanasia agency or  euthanasia
10        technician;
11             (4)  conducting  written  and practical examinations
12        for   applicants   applying   for   certification,    and
13        authorizing certification through the Board; and
14             (5)  recommending  that  the Board suspend or revoke
15        certifications when necessary.
16        (f)  The Euthanasia Task  Force  shall  develop  training
17    sessions  and  materials  that  include  all of the following
18    topics:
19             (1)  the theory and history of euthanasia methods;
20             (2)  animal anatomy and physiology;
21             (3)  proper  animal  handling  to  ease  trauma  and
22        stress;
23             (4)  dosages of chemical agents, record keeping  and
24        documentation  of  usage, storage, handling, and disposal
25        of  expired  drugs  in  accordance  with   the   Illinois
26        Controlled Substances Act;
27             (5)  proper injection techniques; and
28             (6)  confirmation of death
29        (g)  One  or  more  Euthanasia  Task  Force members shall
30    visit each euthanasia agency at least once every 3 years, and
31    shall require a satisfactory demonstration, either  practical
32    or  written,  of  the  skill  of  the  euthanasia technicians
33    employed by the euthanasia agency.
 
                            -4-                LRB9205784LBpc
 1        Section 15.  Agency certification.
 2        (a)  In order to be certified  to  purchase  and  possess
 3    approved  drugs,  euthanasia agencies shall be inspected by a
 4    member of the Euthanasia Task  Force  and  shall  demonstrate
 5    that  the  euthanasia  agency  meets  all  of  the  following
 6    criteria:
 7             (1)  Approved  drugs  are  kept in a securely locked
 8        cabinet or a metal safe when  not  in  use.  A  temporary
 9        storage  cabinet may be used when a euthanasia technician
10        is on duty and animals are being  euthanized  during  the
11        workday.   The  cabinet  shall  be  constructed of strong
12        material and shall be securely locked.  The key  to  this
13        cabinet  shall  be  available  only  to  veterinarians or
14        euthanasia technicians.
15             (2)  Approved drugs are properly labeled and include
16        all of the  information required  by  State  and  federal
17        law.
18             (3)  All records are filed in chronological order in
19        a  binder that is labeled with the name of the agency and
20        that is maintained for 3  years.  The  euthanasia  agency
21        shall submit a copy of its records to the Euthanasia Task
22        Force on an annual basis.
23             (4)  The  conditions  of  the site shall be properly
24        constructed and maintained including, without limitation,
25        proper disposal of medical waste,  regular  cleaning  and
26        disinfecting,   bright   and   even   lighting,   an  air
27        temperature range  that  is  reasonably  comfortable  for
28        personnel   and  animals,  and  an  adequate  ventilation
29        system.
30        (b)  A certification may be renewed upon  the  successful
31    completion  of  a  facility  inspection  by a Euthanasia Task
32    Force member and the payment of the annual renewal fee.
33        (c)  The euthanasia agency  shall  notify  the  Board  in
34    writing  within  30 days of the time that the employment of a
 
                            -5-                LRB9205784LBpc
 1    euthanasia  technician  is  terminated  from  the  euthanasia
 2    agency.

 3        Section 20.  Technician certification; duties.
 4        (a)  Euthanasia technicians shall have had instruction in
 5    the proper methods of humane euthanasia, animal  anatomy  and
 6    physiology,  proper animal handling, confirmation of death in
 7    an animal, security, record keeping,  and  any  other  skills
 8    that  are  deemed  necessary  by  the  Board.   In  addition,
 9    euthanasia  technicians shall have additional training in the
10    proper use and  handling  of  approved  restraint  drugs  and
11    equipment.
12        (b)  Technicians  shall  be  given  a written examination
13    following 15 hours of euthanasia training.   Technicians  who
14    pass  the  written  examination  will  be  eligible  for  the
15    practical   examination   for   certification  as  euthanasia
16    technicians.
17        (c)  Applicants for euthanasia technician positions shall
18    be at least 18 years of age and shall demonstrate proficiency
19    in humane euthanasia standards, which shall  be  demonstrated
20    in the presence of one or more Euthanasia Task Force members,
21    after  the  animals have been scanned for microchips.  Humane
22    euthanasia standards shall include:
23             (1)  Proper performance of intravenous injections on
24        dogs and intraperitoneal  injections  on  both  dogs  and
25        cats.  Intracardiac  injections shall not be required and
26        are  to  be  performed  only  on  anaesthetized,  heavily
27        sedated, and comatose animals.   Oral  administration  of
28        approved drugs is permitted for any animal that cannot be
29        captured  or  restrained  without serious danger to human
30        safety.
31             (2)  Proper record keeping,  including  the  species
32        and  approximate  weight  of  each  animal administered a
33        drug, the amount of the drug that was  administered,  and
 
                            -6-                LRB9205784LBpc
 1        the   signature   of   the   euthanasia   technician  who
 2        administered the drug.
 3             (3)  Understanding and  concern  for  the  needs  of
 4        individual  animals.  The  use of control sticks, squeeze
 5        gates, nets and squeeze cages, or other restraint devices
 6        shall  be  limited  to  fractious,  feral,   vicious   or
 7        dangerous  animals. Control sticks shall never be used on
 8        cats,  except  in  such  extreme  cases  where  no  other
 9        sedation methods can be used.
10             (4)  Knowledge and the ability to  verify  death  by
11        using   a   cardiac  puncture  or  a  stethoscope  or  by
12        recognizing the signs of rigor mortis.
13        (d)  An applicant shall not be certified as a  euthanasia
14    technician  until such time as the applicant has demonstrated
15    proficiency  in  the  practical  examination  that  shall  be
16    conducted  following  the  applicant  having   satisfactorily
17    passed   the   written   exam.    Certification  and  renewal
18    examinations shall be conducted every 3 years.
19        (e)  Notwithstanding the provisions of subsection (b)  of
20    this  Section,  an  applicant who has passed the written exam
21    may  serve  as  a  euthanasia  technician  under  the  direct
22    supervision of a veterinarian or euthanasia technician  until
23    the  next training course and practical exam are conducted by
24    a Euthanasia Task Force member.
25        (f)  Upon  termination  from  a  euthanasia   agency,   a
26    euthanasia  technician  shall  not  perform animal euthanasia
27    until he or she is employed by another  certified  euthanasia
28    agency.
29        (g)  Euthanasia   agency  certifications  and  euthanasia
30    technician certifications expire 36 months from the  date  of
31    issuance.    Euthanasia   agency  and  euthanasia  technician
32    certifications may be renewed upon the successful  completion
33    of  a  written or practical examination to be administered by
34    the Euthanasia Task Force and payment of the  annual  renewal
 
                            -7-                LRB9205784LBpc
 1    fee.
 2        (h)  The  duties of a euthanasia technician shall include
 3    but are not limited to:
 4             (1)  preparing animals for euthanasia  and  scanning
 5        for microchips;
 6             (2)  accurately  recording  the dosages administered
 7        and the amount of drugs wasted;
 8             (3)  ordering supplies;
 9             (4)  maintaining  the  security  of  all  controlled
10        substances and drugs;
11             (5)  humanely euthanizing animals; and
12             (6)  properly disposing of euthanized animals  after
13        verification of death.
14        (i)  A certified euthanasia technician does not engage in
15    the  practice  of  veterinary medicine when performing duties
16    set forth in this Act.
17        (j)  Discipline  shall  be  imposed  for   one   or   any
18    combination of the following, without limitation:
19             (1)  failing to carry out the duties of a euthanasia
20        technician;
21             (2)  abusing the use of any chemical substance;
22             (3)  selling,    stealing,    or   giving   chemical
23        substances away;
24             (4)  abetting anyone in  the  activities  listed  in
25        this subsection (j);
26             (5)  euthanizing  animals without proper supervision
27        while on a probationary status; or
28             (6)  violating  any  provision  of  this  Act,   the
29        Illinois  Controlled  Substances  Act,  the rules adopted
30        under these Acts or any rules adopted by  the  Department
31        of  Professional Regulation concerning the euthanizing of
32        animals.
33        (k)  A violation of any of the provisions  of  subsection
34    (j)  of  this  Section shall be grounds for the suspension or
 
                            -8-                LRB9205784LBpc
 1    revocation of the certification.
 2        (l)  All  fees  shall  be   paid   prior   to   training,
 3    examination,  certification,  and  renewal.   Fees  collected
 4    under this Act are nonrefundable.

 5        Section  25.  Grandfathering  provision.   The Department
 6    may  issue  certification  to  a  euthanasia  technician  who
 7    presents proof in a manner established by the Department that
 8    he or she has been licensed  or  certified  by  the  American
 9    Humane  Association, the National Animal Control Association,
10    the Humane Society of Illinois, the  Illinois  Federation  of
11    Humane Societies, or the United States Humane Society, within
12    the 5 years preceding the effective date of this Act.

13        Section   30.  Reciprocity.    An  applicant,  who  is  a
14    euthanasia technician registered or licensed under  the  laws
15    of  another  state or territory of the United States that has
16    requirements  that   are   substantially   similar   to   the
17    requirements  of  this Act, may be granted certification as a
18    euthanasia technician in this State without examination, upon
19    presenting satisfactory proof  to  the  Department  that  the
20    applicant  has been engaged in the practice of euthanasia for
21    a period of not less than one year and upon  payment  of  the
22    required fee.

23        Section 35.  Procedures for euthanasia.
24        (a)  Only  euthanasia  drugs  and commercially compressed
25    carbon monoxide, subject to  the  limitations  imposed  under
26    subsection (b) of this Section, shall be used for the purpose
27    of  humanely euthanizing injured, sick, homeless, or unwanted
28    companion animals in an animal shelter or an  animal  control
29    agency.
30        (b)  Commercially  compressed carbon monoxide may be used
31    as a permitted method  of  euthanasia  provided  that  it  is
 
                            -9-                LRB9205784LBpc
 1    performed  in a commercially manufactured chamber pursuant to
 2    the guidelines set forth in the most  recent  report  of  the
 3    AVMA Panel on Euthanasia.  Different species of animals shall
 4    not  be  placed  in  the  chamber together. The chamber shall
 5    never be overcrowded and each animal shall be  able  to  make
 6    normal  postural  adjustments.  A chamber that is designed to
 7    euthanize more than one animal at a  time  must  be  equipped
 8    with  independent  sections or cages to separate incompatible
 9    animals. The interior of the chamber must  be  well  lit  and
10    equipped  with  view-ports,  a  regulator,  and a flow meter.
11    Monitoring equipment must be used at  all  times  during  the
12    operation.   Animals  that  are  under  4 months of age, old,
13    injured, or sick may not be euthanized  by  carbon  monoxide.
14    Animals  shall  remain  in  the  chamber and be exposed for a
15    minimum  of  20  minutes.  Confirmation  of  death  shall  be
16    determined for each animal via cardiac  puncture,  use  of  a
17    stethoscope   to   verify  lack  of  respiration  or  cardiac
18    activity, or by observation  of  rigor  mortis.  The  animals
19    shall  be  disposed  of  in accordance with the Illinois Dead
20    Animal Disposal Act.  The chamber shall be cleaned thoroughly
21    after each use.  Staff members shall  be  fully  notified  of
22    potential health risks.

23        Section  40.  Procurement  and administration of approved
24    drugs.
25        (a)  A euthanasia agency  may  directly  obtain  approved
26    drugs  for  the  euthanization  of  animals  and a euthanasia
27    technician  may  administer  the  drugs,  provided  that  the
28    following procedures are adhered to:
29             (1)  A euthanasia agency shall appoint a person  who
30        will  be  responsible for ordering the approved drugs and
31        who  shall  submit  an  application  for   the   agency's
32        registration  as  a euthanasia agency practitioner to the
33        DEA.   The  euthanasia  agency  shall  also  designate  a
 
                            -10-               LRB9205784LBpc
 1        euthanasia technician who shall be  responsible  for  the
 2        security of the agency's approved drugs.
 3             (2)  A  designated euthanasia technician shall apply
 4        for a controlled substance license  from  the  Department
 5        under  the  designee's  name  and  using  the  euthanasia
 6        agency's DEA registration number.
 7        (b)  After  the  euthanasia  agency  has  received  a DEA
 8    registration number and the designated euthanasia  technician
 9    has   received   a  controlled  substance  license  from  the
10    Department, the authorizing agency may order and purchase any
11    approved drugs.
12        (c)  Euthanasia  technicians   employed   by   euthanasia
13    agencies  and  registered  with  the  Department  may perform
14    euthanasia by the administration of approved drugs.

15        Section    45.  Unacceptable    agents.      Unacceptable
16    euthanasia agents for use in animal shelter or animal control
17    facilities are those  physical or chemical agents or chambers
18    that  are  not  authorized  under this Act including, but not
19    limited to, a chloroform chamber, a decompression chamber,  a
20    non-penetrating   captive   bolt,   physical   or  electrical
21    stunning,  injection  of  an  air  embolism,  exsanguination,
22    rapid freezing, drowning, succinylcholine chloride, nicotine,
23    chloral hydrate, magnesium sulfate, cyanide, and strychnine.

24        Section   50.  Inspection  deficiencies.   If  there  are
25    inspection deficiencies with either a euthanizing agency or a
26    euthanasia technician, a Euthanasia Task Force  member  shall
27    document  in  writing  the  areas where correction is needed.
28    The euthanizing agency or  the  euthanasia  technician  shall
29    make  the  necessary corrections within 30 days of receipt of
30    notice of deficiency and a Euthanasia Task Force member shall
31    re-inspect within 90 days of the date of the  initial  notice
32    of deficiency.  If the deficiency has not been corrected, the
 
                            -11-               LRB9205784LBpc
 1    certification  may  be suspended or revoked by the Euthanasia
 2    Task Force. If a certification  is  revoked,  the  Euthanasia
 3    Task  Force  shall  so notify the Department and the euthasia
 4    performed at the facility must be performed by a veterinarian
 5    or the animals  must  be  transported  to  another  certified
 6    euthanasia agency.

 7        Section  55.  Violations.   Any  person  practicing  as a
 8    euthanasia  technician  and  any  agency   operating   as   a
 9    euthanasia agency without possessing a valid certification or
10    a  temporary  permit  is  in violation of this Act and may be
11    subject to all the penalties provided under this Act.

12        Section 60.  Exemption from liability.  An instructor  of
13    euthanasia  techniques  or  a veterinarian who engages in the
14    instructing of euthanasia technicians, in a  course  approved
15    by  the  Department,  shall  not  incur any civil or criminal
16    liability for any  subsequent  misuse  or  malpractice  of  a
17    euthanasia technician who has attended the course.

18        Section 65.  Penalties.
19        (a)  In  addition to any other penalty provided by law, a
20    person who violates any provision of this  Act  shall  pay  a
21    civil  penalty  in  an  amount  not to exceed $5,000 for each
22    offense as determined by the Department.
23        (b)  The Department has the authority to investigate  all
24    uncertified euthanasia activity.
25        (c)  The civil penalty shall be paid within 60 days after
26    the  effective date of the order imposing civil penalty.  The
27    order shall constitute a  judgement  and  may  be  filed  and
28    executed  in  the same manner as any judgement from any court
29    of record.
30        (d)  All monies collected under  this  Section  shall  be
31    deposited into the Professional Regulation Evidence Fund.
 
                            -12-               LRB9205784LBpc
 1        Section  70.  The  Illinois  Controlled Substances Act is
 2    amended by changing Section 102 and  adding  Section  321  as
 3    follows:

 4        (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102)
 5        Sec.  102.  Definitions.  As used in this Act, unless the
 6    context otherwise requires:
 7        (a)  "Addict" means any person who  habitually  uses  any
 8    drug,  chemical,  substance  or  dangerous  drug  other  than
 9    alcohol  so  as to endanger the public morals, health, safety
10    or welfare or who  is  so  far  addicted  to  the  use  of  a
11    dangerous  drug or controlled substance other than alcohol as
12    to have lost the power of self control with reference to  his
13    addiction.
14        (b)  "Administer"  means  the  direct  application  of  a
15    controlled   substance,  whether  by  injection,  inhalation,
16    ingestion, or any other means, to the body of  a  patient  or
17    research subject by:
18             (1)  a  practitioner  (or,  in  his presence, by his
19        authorized agent), or
20             (2)  the patient or research subject at  the  lawful
21        direction of the practitioner.
22        (c)  "Agent"  means  an  authorized  person  who  acts on
23    behalf of or at the direction of a manufacturer, distributor,
24    or dispenser.  It does  not  include  a  common  or  contract
25    carrier,  public  warehouseman  or employee of the carrier or
26    warehouseman.
27        (c-1)  "Anabolic Steroids" means  any  drug  or  hormonal
28    substance,   chemically   and  pharmacologically  related  to
29    testosterone   (other   than   estrogens,   progestins,   and
30    corticosteroids) that promotes muscle growth, and includes:
31                  (i)  boldenone,
32                  (ii)  chlorotestosterone,
33                  (iii)  chostebol,
 
                            -13-               LRB9205784LBpc
 1                  (iv)  dehydrochlormethyltestosterone,
 2                  (v)  dihydrotestosterone,
 3                  (vi)  drostanolone,
 4                  (vii)  ethylestrenol,
 5                  (viii)  fluoxymesterone,
 6                  (ix)  formebulone,
 7                  (x)  mesterolone,
 8                  (xi)  methandienone,
 9                  (xii)  methandranone,
10                  (xiii)  methandriol,
11                  (xiv)  methandrostenolone,
12                  (xv)  methenolone,
13                  (xvi)  methyltestosterone,
14                  (xvii)  mibolerone,
15                  (xviii)  nandrolone,
16                  (xix)  norethandrolone,
17                  (xx)  oxandrolone,
18                  (xxi)  oxymesterone,
19                  (xxii)  oxymetholone,
20                  (xxiii)  stanolone,
21                  (xxiv)  stanozolol,
22                  (xxv)  testolactone,
23                  (xxvi)  testosterone,
24                  (xxvii)  trenbolone, and
25                  (xxviii)  any salt, ester, or isomer of a  drug
26             or  substance described or listed in this paragraph,
27             if that  salt,  ester,  or  isomer  promotes  muscle
28             growth.
29        Any  person who is otherwise lawfully in possession of an
30    anabolic steroid, or  who  otherwise  lawfully  manufactures,
31    distributes, dispenses, delivers, or possesses with intent to
32    deliver  an  anabolic  steroid,  which  anabolic  steroid  is
33    expressly   intended   for   and   lawfully   allowed  to  be
34    administered through implants to livestock or other  nonhuman
 
                            -14-               LRB9205784LBpc
 1    species, and which is approved by the Secretary of Health and
 2    Human  Services for such administration, and which the person
 3    intends to  administer  or  have  administered  through  such
 4    implants,  shall  not  be  considered  to  be in unauthorized
 5    possession  or   to   unlawfully   manufacture,   distribute,
 6    dispense,  deliver,  or  possess  with intent to deliver such
 7    anabolic steroid for purposes of this Act.
 8        (d)  "Administration"   means   the   Drug    Enforcement
 9    Administration,  United  States Department of Justice, or its
10    successor agency.
11        (d-5)  "Animal  control  facility"  means  any   facility
12    operated  by  or under contract for the State, county, or any
13    municipal corporation or political subdivision of  the  State
14    for  the  purpose  of  impounding or harboring seized, stray,
15    homeless,  abandoned,  or  unwanted  dogs,  cats,  and  other
16    animals.  "Animal control facility" also means any veterinary
17    hospital or clinic operated  by  one  or  more  veterinarians
18    licensed  under  the Veterinary Medicine and Surgery Practice
19    Act of 1994 that operates for that purpose in addition to its
20    customary purposes.
21        (d-10)  "Animal  shelter"  means  a  facility   operated,
22    owned,  or  maintained by a duly incorporated humane society,
23    animal welfare society, or other non-profit organization  for
24    the  purpose  of  providing  for  and  promoting the welfare,
25    protection,  and  humane  treatment  of   animals.    "Animal
26    shelter"   also  means  any  veterinary  hospital  or  clinic
27    operated by one or  more  veterinarians  licensed  under  the
28    Veterinary  Medicine  and  Surgery  Practice Act of 1994 that
29    operates for  that  purpose  in  addition  to  its  customary
30    purposes.
31        (e)  "Control" means to add a drug or other substance, or
32    immediate  precursor,  to a Schedule under Article II of this
33    Act whether by transfer from another Schedule or otherwise.
34        (f)  "Controlled Substance" means a drug,  substance,  or
 
                            -15-               LRB9205784LBpc
 1    immediate  precursor  in  the Schedules of Article II of this
 2    Act.
 3        (g)  "Counterfeit   substance"   means    a    controlled
 4    substance,  which,  or  the  container  or labeling of which,
 5    without authorization bears the  trademark,  trade  name,  or
 6    other  identifying  mark,  imprint,  number or device, or any
 7    likeness  thereof,  of  a   manufacturer,   distributor,   or
 8    dispenser  other  than  the  person who in fact manufactured,
 9    distributed, or dispensed the substance.
10        (h)  "Deliver"   or   "delivery"   means   the    actual,
11    constructive   or  attempted  transfer  of  possession  of  a
12    controlled substance, with or without consideration,  whether
13    or not there is an agency relationship.
14        (i)  "Department"  means the Illinois Department of Human
15    Services (as successor to the Department  of  Alcoholism  and
16    Substance Abuse) or its successor agency.
17        (j)  "Department of State Police" means the Department of
18    State  Police  of  the  State  of  Illinois  or its successor
19    agency.
20        (k)  "Department of Corrections" means the Department  of
21    Corrections of the State of Illinois or its successor agency.
22        (l)  "Department  of  Professional  Regulation" means the
23    Department  of  Professional  Regulation  of  the  State   of
24    Illinois or its successor agency.
25        (m)  "Depressant" or "stimulant substance" means:
26             (1)  a  drug  which  contains  any  quantity  of (i)
27        barbituric acid or any of the salts  of  barbituric  acid
28        which  has been designated as habit forming under section
29        502 (d) of the Federal Food, Drug, and Cosmetic  Act  (21
30        U.S.C. 352 (d)); or
31             (2)  a  drug  which  contains  any  quantity  of (i)
32        amphetamine or methamphetamine and any of  their  optical
33        isomers;  (ii) any salt of amphetamine or methamphetamine
34        or any salt of an optical isomer of amphetamine; or (iii)
 
                            -16-               LRB9205784LBpc
 1        any substance which the Department, after  investigation,
 2        has found to be, and by rule designated as, habit forming
 3        because  of  its  depressant  or  stimulant effect on the
 4        central nervous system; or
 5             (3)  lysergic acid diethylamide; or
 6             (4)  any drug  which  contains  any  quantity  of  a
 7        substance  which the Department, after investigation, has
 8        found to have,  and  by  rule  designated  as  having,  a
 9        potential   for   abuse  because  of  its  depressant  or
10        stimulant effect on the central  nervous  system  or  its
11        hallucinogenic effect.
12        (n)  (Blank).
13        (o)  "Director"  means  the Director of the Department of
14    State Police or the Department of Professional Regulation  or
15    his designated agents.
16        (p)  "Dispense"  means  to deliver a controlled substance
17    to an ultimate user or research subject by or pursuant to the
18    lawful order of  a  prescriber,  including  the  prescribing,
19    administering,  packaging, labeling, or compounding necessary
20    to prepare the substance for that delivery.
21        (q)  "Dispenser" means a practitioner who dispenses.
22        (r)  "Distribute"  means  to  deliver,  other   than   by
23    administering or dispensing, a controlled substance.
24        (s)  "Distributor" means a person who distributes.
25        (t)  "Drug"  means  (1) substances recognized as drugs in
26    the   official   United   States   Pharmacopoeia,    Official
27    Homeopathic  Pharmacopoeia  of the United States, or official
28    National Formulary, or any supplement to  any  of  them;  (2)
29    substances  intended  for use in diagnosis, cure, mitigation,
30    treatment, or prevention of disease in man  or  animals;  (3)
31    substances (other than food) intended to affect the structure
32    of  any  function  of  the  body  of  man  or animals and (4)
33    substances intended for use as a  component  of  any  article
34    specified  in clause (1), (2), or (3) of this subsection.  It
 
                            -17-               LRB9205784LBpc
 1    does not include  devices  or  their  components,  parts,  or
 2    accessories.
 3        (t-5)  "Euthanasia  drugs"  means sodium pentobarbital or
 4    any  other  Schedule  III  or   Schedule   II   narcotic   or
 5    non-narcotic euthanasia drug indicated for animal euthanasia,
 6    that  has  first  been  approved  in  writing  for use by the
 7    Federal Drug Authority, the Department, the  Euthanasia  Task
 8    Force, and the Board.
 9        (u)  "Good  faith" means the prescribing or dispensing of
10    a controlled substance  by  a  practitioner  in  the  regular
11    course  of professional treatment to or for any person who is
12    under his treatment for a pathology or condition  other  than
13    that  individual's  physical or psychological dependence upon
14    or addiction to a controlled substance,  except  as  provided
15    herein:   and  application  of the term to a pharmacist shall
16    mean the dispensing of a controlled substance pursuant to the
17    prescriber's order which in the professional judgment of  the
18    pharmacist  is  lawful.   The  pharmacist  shall be guided by
19    accepted professional standards including, but not limited to
20    the following, in making the judgment:
21             (1)  lack   of   consistency    of    doctor-patient
22        relationship,
23             (2)  frequency of prescriptions for same drug by one
24        prescriber for large numbers of patients,
25             (3)  quantities beyond those normally prescribed,
26             (4)  unusual dosages,
27             (5)  unusual  geographic  distances between patient,
28        pharmacist and prescriber,
29             (6)  consistent prescribing of habit-forming drugs.
30        (u-1)  "Home infusion services" means  services  provided
31    by   a   pharmacy   in   compounding   solutions  for  direct
32    administration to a patient in a private residence, long-term
33    care facility, or hospice setting  by  means  of  parenteral,
34    intravenous,   intramuscular,  subcutaneous,  or  intraspinal
 
                            -18-               LRB9205784LBpc
 1    infusion.
 2        (v)  "Immediate precursor" means a substance:
 3             (1)  which the Department has found  to  be  and  by
 4        rule  designated  as  being a principal compound used, or
 5        produced primarily for  use,  in  the  manufacture  of  a
 6        controlled substance;
 7             (2)  which  is  an  immediate  chemical intermediary
 8        used or likely to be used  in  the  manufacture  of  such
 9        controlled substance; and
10             (3)  the  control  of which is necessary to prevent,
11        curtail or  limit  the  manufacture  of  such  controlled
12        substance.
13        (w)  "Instructional   activities"   means   the  acts  of
14    teaching, educating or  instructing  by  practitioners  using
15    controlled  substances within educational facilities approved
16    by the State Board of Education or its successor agency.
17        (x)  "Local authorities" means a  duly  organized  State,
18    County or Municipal peace unit or police force.
19        (y)  "Look-alike substance" means a substance, other than
20    a  controlled  substance  which  (1)  by  overall dosage unit
21    appearance, including shape, color, size,  markings  or  lack
22    thereof,   taste,   consistency,  or  any  other  identifying
23    physical  characteristic  of  the  substance,  would  lead  a
24    reasonable  person  to  believe  that  the  substance  is   a
25    controlled  substance,  or  (2)  is  expressly  or  impliedly
26    represented  to  be  a controlled substance or is distributed
27    under circumstances which would lead a reasonable  person  to
28    believe that the substance is a controlled substance. For the
29    purpose  of  determining  whether the representations made or
30    the circumstances of the distribution would lead a reasonable
31    person to believe the substance to be a controlled  substance
32    under  this  clause (2) of subsection (y), the court or other
33    authority may consider the following factors in  addition  to
34    any other factor that may be relevant:
 
                            -19-               LRB9205784LBpc
 1             (a)  statements  made  by  the  owner  or  person in
 2        control of the substance concerning its  nature,  use  or
 3        effect;
 4             (b)  statements  made to the buyer or recipient that
 5        the substance may be resold for profit;
 6             (c)  whether the substance is packaged in  a  manner
 7        normally  used for the illegal distribution of controlled
 8        substances;
 9             (d)  whether   the   distribution    or    attempted
10        distribution  included an exchange of or demand for money
11        or other  property  as  consideration,  and  whether  the
12        amount  of  the  consideration  was substantially greater
13        than the reasonable retail market value of the substance.
14        Clause (1) of this subsection (y) shall not  apply  to  a
15    noncontrolled  substance in its finished dosage form that was
16    initially introduced  into  commerce  prior  to  the  initial
17    introduction  into  commerce of a controlled substance in its
18    finished dosage form which it may substantially resemble.
19        Nothing in this subsection (y) prohibits  the  dispensing
20    or   distributing  of  noncontrolled  substances  by  persons
21    authorized to dispense and distribute  controlled  substances
22    under  this Act, provided that such action would be deemed to
23    be carried out in good faith  under  subsection  (u)  if  the
24    substances involved were controlled substances.
25        Nothing  in  this subsection (y) or in this Act prohibits
26    the  manufacture,  preparation,   propagation,   compounding,
27    processing,  packaging, advertising or distribution of a drug
28    or drugs by any person registered pursuant to Section 510  of
29    the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
30        (y-1)  "Mail-order  pharmacy"  means  a  pharmacy that is
31    located in a state of the United States, other than Illinois,
32    that delivers, dispenses or distributes, through  the  United
33    States  Postal  Service  or other common carrier, to Illinois
34    residents, any substance which requires a prescription.
 
                            -20-               LRB9205784LBpc
 1        (z)  "Manufacture"  means  the  production,  preparation,
 2    propagation,  compounding,  conversion  or  processing  of  a
 3    controlled  substance,  either  directly  or  indirectly,  by
 4    extraction   from   substances   of   natural   origin,    or
 5    independently  by  means  of  chemical  synthesis,  or  by  a
 6    combination   of   extraction  and  chemical  synthesis,  and
 7    includes any packaging or repackaging  of  the  substance  or
 8    labeling  of  its  container,  except that this term does not
 9    include:
10             (1)  by  an  ultimate  user,  the   preparation   or
11        compounding of a controlled substance for his own use; or
12             (2)  by  a  practitioner,  or  his  authorized agent
13        under  his  supervision,  the  preparation,  compounding,
14        packaging, or labeling of a controlled substance:
15                  (a)  as an incident  to  his  administering  or
16             dispensing  of  a controlled substance in the course
17             of his professional practice; or
18                  (b)  as  an  incident   to   lawful   research,
19             teaching or chemical analysis and not for sale.
20        (z-1)  "Methamphetamine manufacturing chemical" means any
21    of  the  following  chemicals or substances containing any of
22    the following chemicals:  benzyl  methyl  ketone,  ephedrine,
23    methyl  benzyl  ketone, phenylacetone, phenyl-2-propanone, or
24    pseudoephedrine or any of  the  salts,  optical  isomers,  or
25    salts of optical isomers of the above-listed chemicals.
26        (aa)  "Narcotic drug" means any of the following, whether
27    produced directly or indirectly by extraction from substances
28    of  natural  origin,  or  independently  by means of chemical
29    synthesis, or by a combination  of  extraction  and  chemical
30    synthesis:
31             (1)  opium  and  opiate,  and  any  salt,  compound,
32        derivative, or preparation of opium or opiate;
33             (2)  any  salt,  compound,  isomer,  derivative,  or
34        preparation  thereof  which  is  chemically equivalent or
 
                            -21-               LRB9205784LBpc
 1        identical with any  of  the  substances  referred  to  in
 2        clause  (1), but not including the isoquinoline alkaloids
 3        of opium;
 4             (3)  opium poppy and poppy straw;
 5             (4)  coca leaves and any  salts,  compound,  isomer,
 6        salt  of  an  isomer,  derivative, or preparation of coca
 7        leaves including  cocaine  or  ecgonine,  and  any  salt,
 8        compound,  isomer,  derivative,  or  preparation  thereof
 9        which  is  chemically equivalent or identical with any of
10        these substances, but  not  including  decocainized  coca
11        leaves or extractions of coca leaves which do not contain
12        cocaine  or  ecgonine (for the purpose of this paragraph,
13        the  term  "isomer"  includes  optical,  positional   and
14        geometric isomers).
15        (bb)  "Nurse" means a registered nurse licensed under the
16    Nursing and Advanced Practice Nursing Act.
17        (cc)  (Blank).
18        (dd)  "Opiate"  means  any  substance having an addiction
19    forming or addiction sustaining liability similar to morphine
20    or being capable of conversion into a drug  having  addiction
21    forming or addiction sustaining liability.
22        (ee)  "Opium  poppy"  means  the  plant  of  the  species
23    Papaver somniferum L., except its seeds.
24        (ff)  "Parole  and  Pardon  Board"  means  the Parole and
25    Pardon Board of  the  State  of  Illinois  or  its  successor
26    agency.
27        (gg)  "Person"   means   any   individual,   corporation,
28    mail-order  pharmacy,  government or governmental subdivision
29    or agency, business  trust,  estate,  trust,  partnership  or
30    association, or any other entity.
31        (hh)  "Pharmacist"   means   any   person   who  holds  a
32    certificate of registration as  a  registered  pharmacist,  a
33    local   registered   pharmacist  or  a  registered  assistant
34    pharmacist under the Pharmacy Practice Act of 1987.
 
                            -22-               LRB9205784LBpc
 1        (ii)  "Pharmacy" means any store, ship or other place  in
 2    which  pharmacy  is  authorized  to  be  practiced  under the
 3    Pharmacy Practice Act of 1987.
 4        (jj)  "Poppy straw" means all parts, except the seeds, of
 5    the opium poppy, after mowing.
 6        (kk)  "Practitioner"  means  a  physician   licensed   to
 7    practice  medicine  in all its branches, dentist, podiatrist,
 8    veterinarian, scientific investigator, pharmacist,  physician
 9    assistant, advanced practice nurse, licensed practical nurse,
10    registered nurse, hospital, laboratory, or pharmacy, or other
11    person  licensed, registered, or otherwise lawfully permitted
12    by the United States or this State to  distribute,  dispense,
13    conduct  research  with  respect  to,  administer  or  use in
14    teaching or chemical analysis, a controlled substance in  the
15    course of professional practice or research.
16        (ll)  "Pre-printed    prescription"   means   a   written
17    prescription  upon  which  the  designated  drug   has   been
18    indicated prior to the time of issuance.
19        (mm)  "Prescriber" means a physician licensed to practice
20    medicine   in   all  its  branches,  dentist,  podiatrist  or
21    veterinarian who issues a prescription, a physician assistant
22    who issues a prescription  for  a  Schedule  III,  IV,  or  V
23    controlled  substance  in  accordance with Section 303.05 and
24    the written guidelines required  under  Section  7.5  of  the
25    Physician  Assistant  Practice  Act  of  1987, or an advanced
26    practice nurse with prescriptive authority in accordance with
27    Section 303.05 and a written  collaborative  agreement  under
28    Sections 15-15 and 15-20 of the Nursing and Advanced Practice
29    Nursing Act.
30        (nn)  "Prescription"  means  a lawful written, facsimile,
31    or verbal order of a physician licensed to practice  medicine
32    in  all its branches, dentist, podiatrist or veterinarian for
33    any controlled substance, of  a  physician  assistant  for  a
34    Schedule  III,  IV,  or  V controlled substance in accordance
 
                            -23-               LRB9205784LBpc
 1    with Section 303.05 and the written guidelines required under
 2    Section 7.5 of the Physician Assistant Practice Act of  1987,
 3    or  of  an  advanced practice nurse who issues a prescription
 4    for  a  Schedule  III,  IV,  or  V  controlled  substance  in
 5    accordance with Section 303.05 and  a  written  collaborative
 6    agreement  under  Sections 15-15 and 15-20 of the Nursing and
 7    Advanced Practice Nursing Act.
 8        (oo)  "Production"  or   "produce"   means   manufacture,
 9    planting, cultivating, growing, or harvesting of a controlled
10    substance.
11        (pp)  "Registrant"  means every person who is required to
12    register under Section 302 of this Act.
13        (qq)  "Registry number" means the number assigned to each
14    person authorized to handle controlled substances  under  the
15    laws of the United States and of this State.
16        (rr)  "State"  includes  the  State  of  Illinois and any
17    state, district, commonwealth, territory, insular  possession
18    thereof,  and  any area subject to the legal authority of the
19    United States of America.
20        (ss)  "Ultimate  user"  means  a  person   who   lawfully
21    possesses  a  controlled substance for his own use or for the
22    use of a member of his household or for administering  to  an
23    animal owned by him or by a member of his household.

24        (720 ILCS 570/321 new)
25        Sec.  321.  Animal  control  facility  and animal shelter
26    registration.  An animal shelter or animal  control  facility
27    may  apply  to  the Department of Professional Regulation for
28    registration as a euthanasia agency practitioner as  provided
29    for in Section 40 for the sole purpose of being authorized to
30    purchase, possess, and administer the Schedule II drug sodium
31    pentobarbital  and  Schedule III drugs in a manufactured form
32    the  sole  use  of  which  is  to  euthanize  injured,  sick,
33    homeless, or unwanted domestic pets and animals.  Any  animal
 
                            -24-               LRB9205784LBpc
 1    shelter  or  animal  control facility so registered shall not
 2    permit  a  person  to  administer  sodium  pentobarbital   or
 3    Schedule   III  drugs  unless  the  person  has  demonstrated
 4    adequate  knowledge  of  the  potential  hazards  and  proper
 5    techniques to  be  used  in  administering  this  drug.   The
 6    Department  of Professional Regulation shall promulgate rules
 7    that it deems necessary to insure strict compliance with  the
 8    provisions  of  this Section.  The Department of Professional
 9    Regulation  may   suspend   or   revoke   registration   upon
10    determining    that    the    person   administering   sodium
11    pentobarbital has  not  demonstrated  adequate  knowledge  as
12    provided  in  this  Section.   This  authority  is granted in
13    addition to any other power to suspend or revoke registration
14    as provided by law.

[ Top ]